Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00137566Phase 4Unknown
Phase 4, randomised trial in Malaria comparing 1 Paracetamol with 2 Placebo (2 arms). Primary endpoints: Parasite clearance time at 35 days and Recrudescence rate at 35 days. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00137566.